Korean pharmaceutical MGmed decided to change the company’s name to Cancer Rop Co. to refocus company efforts on developing cancer drugs, at a general shareholders’ meeting Wednesday.
MGmed, established in 2001, had specialized in developing molecular diagnostic techniques for various genetic diseases.
The company also named Lee Jang-woo as its new CEO.
Marian Chu
yjc@docdocdoc.co.kr